FASLG and neoplasm: FasL has recently been shown in rodent transplantation studies to possess proinflammatory activity (Allison et al, 1997; Seino et al, 1997a), suggesting that expression of this protein, instead of protecting tumour cells from the immune response, could in fact be detrimental to tumour survival.